Correlation Between Cardiol Therapeutics and Appili Therapeutics

Can any of the company-specific risk be diversified away by investing in both Cardiol Therapeutics and Appili Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardiol Therapeutics and Appili Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cardiol Therapeutics Class and Appili Therapeutics, you can compare the effects of market volatilities on Cardiol Therapeutics and Appili Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardiol Therapeutics with a short position of Appili Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardiol Therapeutics and Appili Therapeutics.

Diversification Opportunities for Cardiol Therapeutics and Appili Therapeutics

-0.73

Correlation Coefficient

Cardiol Therapeutics  Appili Therapeutics

Pay attention - limited upside

The 3 months correlation between Cardiol and Appili is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Cardiol Therapeutics Class and Appili Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Appili Therapeutics and Cardiol Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardiol Therapeutics Class are associated (or correlated) with Appili Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Appili Therapeutics has no effect on the direction of Cardiol Therapeutics i.e., Cardiol Therapeutics and Appili Therapeutics go up and down completely randomly.

Pair Corralation between Cardiol Therapeutics and Appili Therapeutics

Assuming the 90 days trading horizon Cardiol Therapeutics Class is expected to generate 0.32 times more return on investment than Appili Therapeutics. However, Cardiol Therapeutics Class is 3.16 times less risky than Appili Therapeutics. It trades about 0.1 of its potential returns per unit of risk. Appili Therapeutics is currently generating about -0.02 per unit of risk. If you would invest  132.00  in Cardiol Therapeutics Class on April 20, 2025 and sell it today you would earn a total of  29.00  from holding Cardiol Therapeutics Class or generate 21.97% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Cardiol Therapeutics Class  vs.  Appili Therapeutics

Cardiol Therapeutics

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Cardiol Therapeutics Class are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Cardiol Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Appili Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Appili Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in August 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Cardiol Therapeutics and Appili Therapeutics

The main advantage of trading using opposite Cardiol Therapeutics and Appili Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardiol Therapeutics position performs unexpectedly, Appili Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Appili Therapeutics will offset losses from the drop in Appili Therapeutics' long position.

The idea behind Cardiol Therapeutics Class and Appili Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.